# Sheikh Shakhbout Medical City, Abu Dhabi

Source: https://onco.cc/institutions/sheikh-shakhbout-medical-city/  
OnCo record `sheikh-shakhbout-medical-city` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A public hospital in Abu Dhabi for serious and complex care, run with Mayo Clinic, whose cancer services include a radiation therapy department opened in 2023. It is a site for an international trial in cancers with RET changes.

## Summary

Sheikh Shakhbout Medical City is a joint venture between the Abu Dhabi Health Services Company (SEHA) and Mayo Clinic, established in 2019, with 742 beds and care in 46 specialties (hospital release, October 2023). In October 2023 it opened a radiation therapy department, developed with Mayo Clinic, with Varian TrueBeam linear accelerators and capacity for 50 treatment sessions a day, offering IMRT, VMAT, conformal radiotherapy, stereotactic radiotherapy and radiosurgery, total body irradiation and respiratory-managed radiotherapy in curative and palliative settings. ClinicalTrials.gov lists it as a site of the trial of EP0031 (lunbotinib) in advanced RET-altered cancers (NCT05443126). IAEA DIRAC's equipment report, read on 11 November 2026, has no entry for it.

## Fields

- Kind: Institution
- Last checked: 2026-11-11
- Also known as: SSMC
- City: Abu Dhabi, AE
- Type: hospital
- Website: https://ssmc.ae

## Sources

- SSMC: radiation therapy department inaugurated (12 October 2023): https://ssmc.ae/news/sheikh-shakhbout-medical-city-inaugurates-cutting-edge-radiation-therapy-department-to-elevate-expert-cancer-care-in-the-uae/
- ClinicalTrials.gov NCT05443126: site list: https://clinicaltrials.gov/study/NCT05443126

## Connected records

- institutions: [Cleveland Clinic Abu Dhabi](https://onco.cc/institutions/cleveland-clinic-abu-dhabi/), [Emirates Drug Establishment (EDE)](https://onco.cc/institutions/emirates-drug-establishment/), [Mayo Clinic](https://onco.cc/institutions/mayo-clinic/), [Tawam Hospital](https://onco.cc/institutions/tawam-hospital/)
- trials: [A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies](https://onco.cc/trials/nct05443126/)

---
JSON: https://onco.cc/api/v1/entities/sheikh-shakhbout-medical-city.json